Anti‐dsDNA performs best in evaluating disease activity horizontally, and anti‐Nucl is the most sensitive antibody for longitudinal monitoring SLE disease activity and therapeutic efficacy. This evidence concerns the gene UACA and systemic lupus erythematosus.